Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

George E Peoples

Showing results (1-10 of 140) with videos related to

Pageof 14
Sort By:
Military Medicine|July 1, 2006
A novel device developed, tested, and used for warming and maintaining intravenous fluids in a forward surgical team during Operation Enduring FreedomRobert Craig, George E Peoples
Oncology (Williston Park, N.Y.)|May 19, 2016
Injecting Hope--A Review of Breast Cancer VaccinesElizabeth A Mittendorf, George E Peoples
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 4, 2009
Overcoming cancer immune tolerance and escapeGuy T Clifton, George E Peoples
Expert Review of Anticancer Therapy|March 5, 2021
Immunotherapy as a partner for HER2-directed therapiesGuy T Clifton, And George E Peoples
Women'S Health (London, England)|October 7, 2009
HER2/neu vaccines in breast cancerSteven Khoo, Sathibalan Ponniah, George E Peoples
Vaccine|September 23, 2015
Critical issues in cancer vaccine trial designGuy T Clifton, Holbrook E Kohrt, George E Peoples
Immunotherapy|November 17, 2015
Adjuvant HER2/neu peptide cancer vaccines in breast cancerGuy T Clifton, Elizabeth A Mittendorf, George E Peoples
Military Medicine|July 9, 2005
The 274th Forward Surgical Team experience during Operation Enduring FreedomGeorge E Peoples, Tad Gerlinger, Robert Craig, et al.
Cancer|September 1, 2007
Breast cancer vaccines: promise for the future or pipe dream?Elizabeth A Mittendorf, George E Peoples, S Eva Singletary
Future Oncology (London, England)|April 6, 2016
The development and use of the E75 (HER2 369-377) peptide vaccineGuy T Clifton, George E Peoples, Elizabeth A Mittendorf
Pageof 14

Showing results (1-10 of 140) with videos related to

Sort By:
Pageof 14
Military Medicine|July 1, 2006
A novel device developed, tested, and used for warming and maintaining intravenous fluids in a forward surgical team during Operation Enduring FreedomRobert Craig, George E Peoples
Oncology (Williston Park, N.Y.)|May 19, 2016
Injecting Hope--A Review of Breast Cancer VaccinesElizabeth A Mittendorf, George E Peoples
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 4, 2009
Overcoming cancer immune tolerance and escapeGuy T Clifton, George E Peoples
Expert Review of Anticancer Therapy|March 5, 2021
Immunotherapy as a partner for HER2-directed therapiesGuy T Clifton, And George E Peoples
Women'S Health (London, England)|October 7, 2009
HER2/neu vaccines in breast cancerSteven Khoo, Sathibalan Ponniah, George E Peoples
Vaccine|September 23, 2015
Critical issues in cancer vaccine trial designGuy T Clifton, Holbrook E Kohrt, George E Peoples
Immunotherapy|November 17, 2015
Adjuvant HER2/neu peptide cancer vaccines in breast cancerGuy T Clifton, Elizabeth A Mittendorf, George E Peoples
Military Medicine|July 9, 2005
The 274th Forward Surgical Team experience during Operation Enduring FreedomGeorge E Peoples, Tad Gerlinger, Robert Craig, et al.
Cancer|September 1, 2007
Breast cancer vaccines: promise for the future or pipe dream?Elizabeth A Mittendorf, George E Peoples, S Eva Singletary
Future Oncology (London, England)|April 6, 2016
The development and use of the E75 (HER2 369-377) peptide vaccineGuy T Clifton, George E Peoples, Elizabeth A Mittendorf
Pageof 14